Gene Mack - Net Worth and Insider Trading

Gene Mack Net Worth

The estimated net worth of Gene Mack is at least $20,592 dollars as of 2024-09-21. Gene Mack is the CFO and Interim CEO of Gain Therapeutics Inc and owns about 14,400 shares of Gain Therapeutics Inc (GANX) stock worth over $20,592. Details can be seen in Gene Mack's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gene Mack has not made any transactions after 2024-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gene Mack

To

Gene Mack Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gene Mack owns 1 companies in total, including SELLAS Life Sciences Group Inc (SLS) .

Click here to see the complete history of Gene Mack’s form 4 insider trades.

Insider Ownership Summary of Gene Mack

Ticker Comapny Transaction Date Type of Owner
SLS SELLAS Life Sciences Group Inc 2018-04-20 CFO and Treasurer

Gene Mack Latest Holdings Summary

Gene Mack currently owns a total of 1 stock. Gene Mack owns 14,400 shares of Gain Therapeutics Inc (GANX) as of August 9, 2024, with a value of $20,592.

Latest Holdings of Gene Mack

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GANX Gain Therapeutics Inc 2024-08-09 14,400 1.43 20,592

Holding Weightings of Gene Mack


Gene Mack Form 4 Trading Tracker

According to the SEC Form 4 filings, Gene Mack has made a total of 1 transactions in Gain Therapeutics Inc (GANX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Gain Therapeutics Inc is the acquisition of 14,400 shares on August 9, 2024, which cost Gene Mack around $14,544.

Insider Trading History of Gene Mack

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gene Mack Trading Performance

GuruFocus tracks the stock performance after each of Gene Mack's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gene Mack is %. GuruFocus also compares Gene Mack's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gene Mack within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gene Mack's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gene Mack

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Gene Mack Ownership Network

Ownership Network List of Gene Mack

No Data

Ownership Network Relation of Gene Mack

Insider Network Chart

Gene Mack Owned Company Details

What does SELLAS Life Sciences Group Inc do?

Who are the key executives at SELLAS Life Sciences Group Inc?

Gene Mack is the CFO and Treasurer of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .

SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

SELLAS Life Sciences Group Inc Insider Transactions

No Available Data

Gene Mack Mailing Address

Above is the net worth, insider trading, and ownership report for Gene Mack. You might contact Gene Mack via mailing address: 315 Madison Ave, New York Ny 10017.

Discussions on Gene Mack

No discussions yet.